Literature DB >> 10319923

Reflections on randomised controlled trials in surgery.

M Baum1.   

Abstract

Mesh：

Year:  1999        PMID： 10319923     DOI： 10.1016/s0140-6736(99)90220-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  The ethics of innovation. Should innovative surgery be exempt from clinical trials and regulations?

Authors:  Vicki Brower
Journal:  EMBO Rep       Date:  2003-04       Impact factor: 8.807

Review 2.  Remains of the day: biliary complications related to single-port laparoscopic cholecystectomy.

Authors:  Pierre Allemann; Nicolas Demartines; Markus Schäfer
Journal:  World J Gastroenterol       Date:  2014-01-21       Impact factor: 5.742

Review 3.  Quality improvement report: Improving design and conduct of randomised trials by embedding them in qualitative research: ProtecT (prostate testing for cancer and treatment) study. Commentary: presenting unbiased information to patients can be difficult.

Authors:  Jenny Donovan; Nicola Mills; Monica Smith; Lucy Brindle; Ann Jacoby; Tim Peters; Stephen Frankel; David Neal; Freddie Hamdy
Journal:  BMJ       Date:  2002-10-05

4.  Enabling recruitment success in bariatric surgical trials: pilot phase of the By-Band-Sleeve study.

Authors:  S Paramasivan; C A Rogers; R Welbourn; J P Byrne; N Salter; D Mahon; H Noble; J Kelly; G Mazza; P Whybrow; R C Andrews; C Wilson; J M Blazeby; J L Donovan
Journal:  Int J Obes (Lond)       Date:  2017-07-03       Impact factor: 5.095

5.  IDEAL framework for surgical innovation 3: randomised controlled trials in the assessment stage and evaluations in the long term study stage.

Authors:  Jonathan A Cook; Peter McCulloch; Jane M Blazeby; David J Beard; Danica Marinac-Dabic; Art Sedrakyan
Journal:  BMJ       Date:  2013-06-18

6.  The Patient Deficit Model Overturned: a qualitative study of patients' perceptions of invitation to participate in a randomized controlled trial comparing selective bladder preservation against surgery in muscle invasive bladder cancer (SPARE, CRUK/07/011).

Authors:  Clare Moynihan; Rebecca Lewis; Emma Hall; Emma Jones; Alison Birtle; Robert Huddart
Journal:  Trials       Date:  2012-11-29       Impact factor: 2.279
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.